Enhertu and Dizziness: What Users Say
Reviews for Enhertu
- Mal...
- Taken for less than 1 month
- March 19, 2024
For Breast Cancer, Metastatic "I had a response/reaction during the first dose that required stopping infusion halfway through. Emergency team came. Received rescue medication and evaluation in the ER. Ruled out cardiac event. Went home okay. Side effects included: profound fatigue, nausea, dizziness, malaise, mouth and nose sores, persistent bad taste, indigestion. By day 12, felt better and was able to do short walks, light social activities, sewing, light gardening, etc. Side effects above persisted but less. Second infusion 21 days later. Received full dose but given at slower rate (over three hours). Tolerated well. Side effects so far (day 0-7) post-infusion are heavier. Extreme exhaustion. Difficult to be out of bed. Nausea, bad taste, indigestion. Vertigo, dizziness, malaise."
- Mal...
- Taken for less than 1 month
- March 19, 2024
For Breast Cancer, Metastatic "I had a response/reaction during the first dose that required stopping infusion halfway through. Emergency team came. Received rescue medication and evaluation in the ER. Ruled out cardiac event. Went home okay. Side effects included: profound fatigue, nausea, dizziness, malaise, mouth and nose sores, persistent bad taste, indigestion. By day 12, felt better and was able to do short walks, light social activities, sewing, light gardening, etc. Side effects above persisted but less. Second infusion 21 days later. Received full dose but given at slower rate (over three hours). Tolerated well. Side effects so far (day 0-7) post-infusion are heavier. Extreme exhaustion. Difficult to be out of bed. Nausea, bad taste, indigestion. Vertigo, dizziness, malaise."
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Frequently asked questions
- What is the success rate of Enhertu in metastatic breast cancer?
- Is Enhertu a chemotherapy drug? What's Enhertu used for?
Are you taking this medicine?
Your review helps others make informed decisions.More about Enhertu (fam-trastuzumab deruxtecan)
- Enhertu consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (31)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- En español
For Breast Cancer, Metastatic "Had 2 treatments with Enhertu. The side effects were bad and did not go away for a long time: dizziness, jitteriness in the entire body, fatigue, weakness, diarrhea, sick stomach, felt unwell all over and inside the body. Never, never would have another treatment with Enhertu!!"